Ann E. Weber

6.4k total citations
78 papers, 3.2k citations indexed

About

Ann E. Weber is a scholar working on Cellular and Molecular Neuroscience, Oncology and Molecular Biology. According to data from OpenAlex, Ann E. Weber has authored 78 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cellular and Molecular Neuroscience, 36 papers in Oncology and 34 papers in Molecular Biology. Recurrent topics in Ann E. Weber's work include Neuropeptides and Animal Physiology (41 papers), Peptidase Inhibition and Analysis (35 papers) and Diabetes Treatment and Management (31 papers). Ann E. Weber is often cited by papers focused on Neuropeptides and Animal Physiology (41 papers), Peptidase Inhibition and Analysis (35 papers) and Diabetes Treatment and Management (31 papers). Ann E. Weber collaborates with scholars based in United States, Germany and United Kingdom. Ann E. Weber's co-authors include David A. Evans, Nancy A. Thornberry, Joseph K. Wu, Mari R. Candelore, Laurie Tota, Huaibing He, Margaret A. Cascieri, Barbara Leiting, Kathryn A. Lyons and Reshma A. Patel and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Ann E. Weber

78 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann E. Weber United States 32 1.4k 1.4k 802 797 692 78 3.2k
William J. Greenlee United States 34 2.0k 1.4× 2.2k 1.6× 251 0.3× 227 0.3× 642 0.9× 161 4.5k
A.L. Johnson United States 29 984 0.7× 2.1k 1.5× 124 0.2× 1.1k 1.4× 578 0.8× 62 4.2k
Emily F. Sabo United States 19 460 0.3× 2.1k 1.5× 394 0.5× 172 0.2× 354 0.5× 32 2.9k
Deepak Dalvie United States 33 831 0.6× 1.7k 1.3× 609 0.8× 164 0.2× 109 0.2× 76 4.0k
Duane A. Burnett United Kingdom 26 1.1k 0.8× 728 0.5× 347 0.4× 130 0.2× 183 0.3× 108 2.6k
Jean‐François Goossens France 26 850 0.6× 1.1k 0.8× 261 0.3× 94 0.1× 278 0.4× 109 2.4k
George A. Doss United States 29 681 0.5× 876 0.6× 519 0.6× 138 0.2× 156 0.2× 95 2.6k
John W. Clader United States 28 1.4k 1.0× 953 0.7× 320 0.4× 85 0.1× 227 0.3× 72 3.1k
Eberhard Heymann Germany 30 315 0.2× 1.1k 0.8× 729 0.9× 188 0.2× 451 0.7× 65 2.4k
Dennis Dean United States 25 571 0.4× 614 0.4× 381 0.5× 183 0.2× 134 0.2× 66 2.0k

Countries citing papers authored by Ann E. Weber

Since Specialization
Citations

This map shows the geographic impact of Ann E. Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann E. Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann E. Weber more than expected).

Fields of papers citing papers by Ann E. Weber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann E. Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann E. Weber. The network helps show where Ann E. Weber may publish in the future.

Co-authorship network of co-authors of Ann E. Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Ann E. Weber. A scholar is included among the top collaborators of Ann E. Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann E. Weber. Ann E. Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bennett, Frank, Alexei V. Buevich, Hsueh‐Cheng Huang, et al.. (2017). Concise syntheses and HCV NS5B polymerase inhibition of (2′R)-3 and (2′S)-2′-ethynyluridine-10 and related nucleosides. Bioorganic & Medicinal Chemistry Letters. 27(23). 5349–5352. 2 indexed citations
3.
4.
Chen, Ping, Charles G. Caldwell, Wallace T. Ashton, et al.. (2011). Synthesis and evaluation of [(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]cyclohexanes and 4-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]piperidines as DPP-4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(6). 1880–1886. 13 indexed citations
5.
Wang, Liping, James Hubert, Sang Hyuck Lee, et al.. (2011). Discovery of pyrimidine carboxamides as potent and selective CCK1 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 21(10). 2911–2915. 11 indexed citations
6.
Cox, Jason M., Anthony Mastracchio, Barbara Leiting, et al.. (2007). Discovery of 3-aminopiperidines as potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(16). 4579–4583. 17 indexed citations
7.
Liang, Gui‐Bai, Xiaoxia Qian, Dennis Feng, et al.. (2007). Optimization of 1,4-diazepan-2-one containing dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters. 17(7). 1903–1907. 27 indexed citations
8.
Thornberry, Nancy A. & Ann E. Weber. (2007). Discovery of JANUVIA™ (Sitagliptin), a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type2 Diabetes.. Current Topics in Medicinal Chemistry. 7(6). 557–568. 154 indexed citations
9.
Biftu, Tesfaye, Giovanna Scapin, Suresh B. Singh, et al.. (2007). Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin. Bioorganic & Medicinal Chemistry Letters. 17(12). 3384–3387. 51 indexed citations
10.
Xu, Jinyou, Lan Wei, Robert J. Mathvink, et al.. (2005). Discovery of potent, selective, and orally bioavailable pyridone-based dipeptidyl peptidase-4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(5). 1346–1349. 14 indexed citations
11.
Xu, Jinyou, Lan Wei, Robert J. Mathvink, et al.. (2005). Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(10). 2533–2536. 57 indexed citations
12.
Ashton, Wallace T., Hong Dong, George A. Doss, et al.. (2004). Diastereoselective synthesis and configuration-dependent activity of (3-substituted-cycloalkyl)glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(4). 859–863. 19 indexed citations
13.
Edmondson, Scott D., Anthony Mastracchio, Jiafang He, et al.. (2003). Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(22). 3983–3987. 28 indexed citations
14.
Stearns, Ralph A., Randy R. Miller, Wei Tang, et al.. (2002). The Pharmacokinetics of a Thiazole Benzenesulfonamide β3-Adrenergic Receptor Agonist and Its Analogs in Rats, Dogs, and Monkeys: Improving Oral Bioavailability. Drug Metabolism and Disposition. 30(7). 771–777. 8 indexed citations
15.
Tang, Wei, Ralph A. Stearns, Randall R. Miller, et al.. (2002). Metabolism of a Thiazole Benzenesulfonamide Derivative, a Potent and Selective Agonist of the Human β3-Adrenergic Receptor, in Rats: Identification of a Novel Isethionic Acid Conjugate. Drug Metabolism and Disposition. 30(7). 778–787. 8 indexed citations
16.
Biftu, Tesfaye, Mari R. Candelore, Margaret A. Cascieri, et al.. (2000). Discovery of an orally bioavailable alkyl oxadiazole β3 adrenergic receptor agonist. Bioorganic & Medicinal Chemistry Letters. 10(13). 1427–1429. 15 indexed citations
17.
Parmee, Emma R., Linda Brockunier, Jiafang He, et al.. (2000). Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human β3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 10(20). 2283–2286. 12 indexed citations
18.
Forrest, Michael J., Gary J. Hom, Mari R. Candelore, et al.. (2000). L-750355, a human ß3-adrenoceptor agonist; in vitro pharmacology and profile of activity in vivo in the rhesus monkey. European Journal of Pharmacology. 407(1-2). 175–181. 8 indexed citations
19.
Candelore, Mari R., Liping Deng, Laurie Tota, et al.. (1999). Potent and selective human beta(3)-adrenergic receptor antagonists.. PubMed. 290(2). 649–55. 112 indexed citations
20.
Shih, Thomas L., Mari R. Candelore, Margaret A. Cascieri, et al.. (1999). L-770,644: A potent and selective human β3 adrenergic receptor agonist with improved oral bioavailability. Bioorganic & Medicinal Chemistry Letters. 9(9). 1251–1254. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William J. Greenlee Breakdown of academic impact, for papers by A.L. Johnson Breakdown of academic impact, for papers by Emily F. Sabo Breakdown of academic impact, for papers by Deepak Dalvie Breakdown of academic impact, for papers by Duane A. Burnett Breakdown of academic impact, for papers by Jean‐François Goossens Breakdown of academic impact, for papers by George A. Doss Breakdown of academic impact, for papers by John W. Clader Breakdown of academic impact, for papers by Eberhard Heymann Breakdown of academic impact, for papers by Dennis Dean
Rankless by CCL
2026